Biotechnology & Pharmaceuticals

The Munich metropolitan region is a leading hub for biotech and pharmaceuticals, characterized by a close network of innovative companies, excellent research, and high-performing life sciences clusters that drive medical progress and new therapies.

With 65,000 employees, the Munich metropolitan region is an outstanding hub for biotechnology, pharmaceuticals, medical technology, and the healthcare industry—collectively known as the life sciences—in Europe. Over 500 companies in the biotechnology and pharmaceutical sectors, including leading firms such as Roche, GlaxoSmithKline, MSD, Hexal, and Sandoz, are based in the Munich metropolitan region.

Accounting for 60 percent of Germany’s electromedical device production and 30 percent of its total medical production, the metropolitan region is one of the leading locations in the field of medical technology.